Brief: Amicus to Pay Biomarin Pharmaceutical $175 Million Merger Termination Fee
Dec 19 (Reuters) - Biomarin Pharmaceutical Inc BMRN.O: BIOMARIN PHARMACEUTICAL INC: UPON TERMINATION OF MERGER AGREEMENT, AMICUS TO PAY BIOMARIN TERMINATION FEE OF $175 MILLION -SEC FILING Source text: [ID:n0001193125-25-325856] Further company coverage: BMRN.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on BioMarin Pharmaceutical
See all newsUS RESEARCH ROUNDUP-Analog Devices, IBM, Qualcomm
Brief: Biomarin Pharmaceutical Expects Q3 2026 Pre-Tax Charges Of $283 Million For Bought Ipr&D Expense
Brief: Biomarin Appoints Cara Bauer As Chief People Officer
Brief: Biomarin Pharmaceutical Enters Settlement And License Agreement With Ascendis Pharma On Sept 24, 2026
U.S. STOCKS ON THE MOVE-GitLab, California utilities, Herbalife